Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2023 | Remaining unmet needs in pediatric Wilms’ tumor

Amy Armstrong, MD, University Hospitals Cleveland Medical Center, Cleveland, OH, comments on unanswered questions regarding the management of Wilms’ tumor in pediatric patients. Due to the very small number of cases, sufficient recruitment of patients for clinical trials are a challenge. Dr Armstrong additionally highlights several studies, including one assessing the molecular characterization of favorable Wilms’ tumor, and another investigating the efficacy of vincristine and irinotecan in anaplastic Wilms’ tumor. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.